Gastric and duodenal safety of daily alendronate

被引:32
作者
Donahue, JG
Chan, KA
Andrade, SE
Beck, A
Boles, M
Buist, DSM
Carey, VJ
Chandler, JM
Chase, GA
Ettinger, B
Fishman, P
Goodman, M
Guess, HA
Gunwitz, JH
LaCroix, AZ
Levin, TR
Platt, R
机构
[1] Harvard Univ, Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[3] Meyers Primary Care Inst, Fallon Healthcare Syst, Worcester, MA USA
[4] Kaiser Permanente, Denver, CO USA
[5] Kaiser Permanente NW, Portland, OR USA
[6] Grp Hlth Cooperat Puget Sound, Seattle, WA USA
[7] Merck & Co Inc, West Point, PA USA
[8] Henry Ford Hlth Syst, Detroit, MI USA
[9] Kaiser Permanente Med Care Program, Oakland, CA 94611 USA
[10] Hlth Partners Res Fdn, Minneapolis, MN USA
[11] Univ Calif San Francisco, Sch Med, San Francisco, CA USA
[12] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02115 USA
[13] Univ Massachusetts, Sch Med, Worcester, MA USA
[14] Harvard Pilgrim Hlth Care, Boston, MA USA
关键词
D O I
10.1001/archinte.162.8.936
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Isolated case reports of gastric ulcers after alendronate sodium use raised concern about the gastroduodenal safety of daily alendronate. This study was conducted to estimate the excess risk of hospitalizations for gastric or duodenal perforations, ulcers, and bleeding associated with alendronate use. Participants and Methods: Study subjects were 6432 men and women, 35 years or older. The subjects were members of 8 health maintenance organizations who were dispensed alendronate from October 1995 through September 1997. There was also a group of 33176 age-, sex-, and health maintenance organization-matched unexposed persons. Because of concerns that osteoporosis might confound the association between alendronate use and perforation, ulcer, or bleeding, a second comparison group of 9776 women, 60 years or older, who had osteoporotic fractures was assembled. Hospitalizations for gastroduodenal events were identified by discharge diagnosis codes in automated claims records, and confirmed by manual record review. Results: Based on the 14 confirmed events in the alendronate group and 35 in the unexposed group, the crude incidence rate ratio of gastroduodenal perforation, ulcer, or bleeding for the alendronate cohort was 3.0. The incidence rate ratio was 1.8 (95% confidence interval, 0.83.9) after control for prior hospitalizations, comorbidity, and recent exposure to prescription nonsteroidal antiinflammatory drugs and oral corticosteroids. The crude incidence ratio rate for the age, sex, and health maintenance organizations-restricted cohort of alendronate users relative to the fracture cohort was 1.1 and the adjusted incidence rate ratio was 1.1 (95% confidence interval, 0.6-2.2). Conclusions: Osteoporosis and related factors appear to play an important role in the relationship between alendronate use and confirmed gastroduodenal perforation, ulcer, or bleeding; a substantial fraction of the increased risk we observed for alendronate users in the unadjusted analysis was the result of confounding.
引用
收藏
页码:936 / 942
页数:7
相关论文
共 35 条
[1]  
AITKEN M., 1989, STAT MODELING GLIM
[2]   Upper gastrointestinal tract safety profile of alendronate -: The Fracture Intervention Trial [J].
Bauer, DC ;
Black, D ;
Ensrud, K ;
Thompson, D ;
Hochberg, M ;
Nevitt, M ;
Musliner, T ;
Freedholm, D .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (04) :517-525
[3]   Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].
Black, DM ;
Cummings, SR ;
Karpf, DB ;
Cauley, JA ;
Thompson, DE ;
Nevitt, MC ;
Bauer, DC ;
Genant, HK ;
Haskell, WL ;
Marcus, R ;
Ott, SM ;
Torner, JC ;
Quandt, SA ;
Reiss, TF ;
Ensrud, KE .
LANCET, 1996, 348 (9041) :1535-1541
[4]   Mortality following fractures in older women - The study of osteoporotic fractures [J].
Browner, WS ;
Pressman, AR ;
Nevitt, MC ;
Cummings, SR .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (14) :1521-1525
[5]   NONTRAUMA MORTALITY IN ELDERLY WOMEN WITH LOW BONE-MINERAL DENSITY [J].
BROWNER, WS ;
SEELEY, DG ;
VOGT, TM ;
CUMMINGS, SR .
LANCET, 1991, 338 (8763) :355-358
[6]  
Buist DSM, 1999, AM J EPIDEMIOL, V149, P275
[7]   Mortality after all major types of osteoporotic fracture in men and women: an observational study [J].
Center, JR ;
Nguyen, TV ;
Schneider, D ;
Sambrook, PN ;
Eisman, JA .
LANCET, 1999, 353 (9156) :878-882
[8]   A CHRONIC DISEASE SCORE WITH EMPIRICALLY DERIVED WEIGHTS [J].
CLARK, DO ;
VONKORFF, M ;
SAUNDERS, K ;
BALUCH, WM ;
SIMON, GE .
MEDICAL CARE, 1995, 33 (08) :783-795
[9]  
Colina RE, 1997, AM J GASTROENTEROL, V92, P704
[10]   BIAS DUE TO MISCLASSIFICATION IN ESTIMATION OF RELATIVE RISK [J].
COPELAND, KT ;
CHECKOWAY, H ;
MCMICHAEL, AJ ;
HOLBROOK, RH .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1977, 105 (05) :488-495